Edition:
United States

Active Biotech AB (ACTI.ST)

ACTI.ST on Stockholm Stock Exchange

4.50SEK
11:29am EDT
Change (% chg)

-0.05kr (-1.10%)
Prev Close
4.55kr
Open
4.55kr
Day's High
4.65kr
Day's Low
4.49kr
Volume
80,954
Avg. Vol
406,285
52-wk High
21.90kr
52-wk Low
4.17kr

ACTI.ST

Chart for ACTI.ST

About

Active Biotech AB is a Sweden-based company that focuses on pharmaceutical research and development in medical fields in which the immune system plays a central role. The Company’s research portfolio primarily includes projects for the development of drugs for the treatment of autoimmune and inflammatory diseases and cancer. As... (more)
No analyst recommendations are available for ACTI.ST.

Overall

Beta: 2.59
Market Cap(Mil.): kr440.55
Shares Outstanding(Mil.): 96.82
Dividend: --
Yield (%): --

Financials

  ACTI.ST Industry Sector
P/E (TTM): -- 78.89 32.56
EPS (TTM): -0.72 -- --
ROI: -18.75 2.83 14.89
ROE: -45.15 5.09 16.13

BRIEF-Active Biotech Q2 operating loss 23.1 mln SEK

* Active biotech ab q2 sales 5.1 million sek Source text for Eikon: Further company coverage: (Reporting By Anna Ringstrom)

Aug 10 2017

BRIEF-Active Biotech appoints Helen Tuvesson as new CEO

* the Board has appointed the company's current CSO Helén Tuvesson as new CEO of Active Biotech AB

Jun 19 2017

BRIEF-Active Biotech: FDA grants Orphan Drug Designation for tasquinimod for multiple myeloma treatment

* Reg-Active biotech: fda grants orphan drug designation for tasquinimod for the treatment of multiple myeloma Source text for Eikon: Further company coverage: (Reporting By Anna Ringstrom)

Apr 12 2017

Earnings vs. Estimates